Orthopedic Bone Cement

Global Orthopedic Bone Cement Market to Reach US$1.8 Billion by 2032

The global market for Orthopedic Bone Cement estimated at US$1.1 Billion in the year 2025, is expected to reach US$1.8 Billion by 2032, growing at a CAGR of 6.8% over the analysis period 2025-2032. Polymethyl Methacrylate (PMMA) Cement, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$881.3 Million by the end of the analysis period. Growth in the Calcium Phosphate Cement (CPC) segment is estimated at 6.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$342.6 Million While China is Forecast to Grow at 10.8% CAGR

The Orthopedic Bone Cement market in the U.S. is estimated at US$342.6 Million in the year 2025. China, the world`s second largest economy, is forecast to reach a projected market size of US$434.0 Million by the year 2032 trailing a CAGR of 10.8% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.8% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Orthopedic Bone Cement Market - Key Trends & Drivers Summarized

Why Is Orthopedic Bone Cement Essential in Joint Replacement Surgeries?

Orthopedic bone cement has become a vital component in joint replacement and repair surgeries, providing a reliable solution for fixing prosthetic implants to bone structures. This cement, typically made from polymethyl methacrylate (PMMA), is widely used in orthopedic procedures such as total hip and knee replacements, where it fills the space between the implant and the bone, creating a stable and durable bond. Bone cement not only anchors the implant securely but also distributes mechanical stress, reducing the risk of implant loosening and ensuring the longevity of the prosthetic. With an aging global population and a rise in joint-related disorders like osteoarthritis, the demand for joint replacement surgeries is growing, and bone cement plays a crucial role in meeting the needs of patients seeking long-term mobility and pain relief. By providing a strong and lasting fixation, orthopedic bone cement is essential in enabling successful surgical outcomes and improving patients` quality of life.

The versatility of orthopedic bone cement in various surgical applications has further cemented its importance in the orthopedic field. In addition to joint replacements, bone cement is used in vertebroplasty and kyphoplasty procedures for spinal fractures, where it helps stabilize vertebrae and alleviate pain. It is also utilized in the repair of complex fractures and bone defects, especially in older patients whose bones are less able to heal naturally. The ability of bone cement to harden quickly, typically within minutes, allows surgeons to complete procedures efficiently, reducing operating time and improving patient recovery rates. This quick-setting property, along with its adaptability to different types of orthopedic implants and procedures, makes bone cement indispensable in modern surgical practices. As minimally invasive procedures and rapid recovery become priorities in healthcare, bone cement’s role in stabilizing and supporting implants is increasingly important in delivering optimal outcomes.

Moreover, advancements in bone cement formulation, such as the development of antibiotic-loaded bone cement, have expanded its utility by adding infection-preventative capabilities. Postoperative infections can be a serious complication in joint replacement surgeries, potentially leading to implant failure. Antibiotic-loaded bone cement, which contains antibiotics within the PMMA matrix, releases these agents gradually, helping to prevent infections at the surgical site. This innovation has proven particularly valuable in high-risk patients and revision surgeries, where infection prevention is critical. As a result, antibiotic-loaded bone cement has become a standard choice in many procedures, improving patient safety and surgical success rates. By offering both mechanical stability and infection prevention, orthopedic bone cement supports a range of critical needs in joint replacement and fracture repair, making it a cornerstone of orthopedic surgery.

How Are Innovations and New Materials Shaping the Orthopedic Bone Cement Market?

Innovations in orthopedic bone cement technology and materials are significantly shaping the market, offering solutions that enhance performance, safety, and ease of use in surgeries. Traditional PMMA-based bone cements are effective, but recent developments have focused on improving cement properties such as radiopacity, biocompatibility, and setting time to meet the evolving demands of orthopedic procedures. Radiopaque additives, for example, are now commonly included in bone cement formulations, making it easier for surgeons to see the cement placement on imaging systems and assess the quality of the fixation post-surgery. This feature is particularly beneficial during revision surgeries or follow-ups, as it helps in detecting any potential issues with implant stability. Innovations like these support surgical precision and post-operative monitoring, addressing the need for more advanced and effective cement solutions.

The introduction of bioactive and biodegradable bone cements marks another significant advancement in the orthopedic bone cement market. Bioactive cements, which include additives like hydroxyapatite or calcium phosphate, promote bone in-growth and improve integration between the implant and the natural bone. These materials encourage natural bone formation, which is especially beneficial for younger patients or those requiring long-term implant stability. Biodegradable cements, on the other hand, are designed to gradually dissolve as the bone heals and regenerates, reducing the need for secondary surgeries. These materials are primarily used in fracture repair and bone defect treatments, where they provide temporary support while minimizing long-term foreign material in the body. As the orthopedic field shifts toward biologically compatible materials that support natural healing, bioactive and biodegradable bone cements offer promising alternatives to traditional PMMA-based solutions, opening new possibilities for more personalized and regenerative treatment approaches.

Advances in minimally invasive orthopedic procedures have also influenced the design and composition of bone cement, leading to products that are easier to handle, inject, and set quickly. Bone cement formulations with optimized viscosity allow for better control and precision during application, reducing the risk of cement leakage and associated complications. Innovations in delivery systems, such as pre-mixed and vacuum-mixed cements, simplify the preparation process for surgeons, ensuring consistent quality and minimizing the risks of air entrapment, which can compromise fixation strength. These user-friendly advancements are particularly valuable in procedures like vertebroplasty, where precise cement application is crucial for stabilizing spinal fractures. As demand for minimally invasive and outpatient orthopedic procedures grows, the market for bone cement formulations that facilitate efficient, reliable, and controlled application is set to expand, meeting the needs of both patients and healthcare providers seeking advanced and accessible solutions.

What Are the Key Benefits of Orthopedic Bone Cement for Patients and Surgeons?

Orthopedic bone cement offers several significant benefits for both patients and surgeons, making it a preferred choice in various orthopedic procedures. For patients, the primary advantage of bone cement is its ability to provide immediate implant stability and support, enabling them to regain mobility and improve quality of life soon after surgery. Bone cement’s rapid hardening properties allow patients to start rehabilitation shortly after the procedure, which is crucial in joint replacement surgeries where early mobility is essential for successful recovery. Additionally, bone cement’s role in securely fixing the implant reduces the likelihood of implant loosening, a common complication in joint replacements that often leads to revision surgeries. With a stable implant, patients experience better functionality, reduced pain, and prolonged implant life, all of which contribute to positive long-term outcomes.

From a surgeon’s perspective, bone cement offers flexibility and reliability, essential in ensuring effective and efficient surgical procedures. Bone cement’s ability to adhere to both metal and bone surfaces enables surgeons to achieve a strong bond between the implant and bone, even in patients with poor bone quality, such as the elderly or those with osteoporosis. This property is particularly valuable in revision surgeries, where compromised bone structure can make implant fixation challenging. The ability of bone cement to fill gaps between the implant and bone ensures comprehensive support, facilitating a secure fit that withstands the physical demands of joint movement. This stability is crucial for high-impact areas like the hips and knees, where mechanical stress is significant. For surgeons, bone cement’s quick setting time and ease of application reduce procedure times and improve patient outcomes, enhancing the efficiency of orthopedic surgeries.

Another critical benefit of orthopedic bone cement is its infection prevention capability, especially when antibiotic-loaded formulations are used. Post-surgical infections can severely impact recovery and often lead to complications that necessitate further interventions. Antibiotic-loaded bone cement releases antimicrobial agents gradually, targeting the surgical site and minimizing the risk of infection. This localized release of antibiotics is particularly valuable in joint replacements and complex fracture repairs, where infection prevention is essential for implant success. By reducing the incidence of infections and associated complications, antibiotic-loaded bone cement contributes to improved patient safety, shorter hospital stays, and fewer postoperative interventions. These benefits, combined with bone cement’s proven durability and adaptability, make it a reliable choice in enhancing patient outcomes and supporting surgeons in delivering high-quality orthopedic care.

What Is Fueling the Growth in the Orthopedic Bone Cement Market?

The growth in the orthopedic bone cement market is driven by several key factors, including the rising incidence of joint-related disorders, advances in surgical techniques, and the increasing demand for minimally invasive procedures. As the global population ages, the prevalence of conditions like osteoarthritis and osteoporosis continues to rise, leading to an increased need for joint replacement surgeries and fracture repairs. Orthopedic bone cement is essential in these procedures, providing the stability and support needed for successful outcomes. The demand for joint replacements, particularly hip and knee replacements, has surged in recent years, and bone cement is critical in ensuring long-lasting, stable implants. As joint replacement surgeries become more common, the market for orthopedic bone cement is expected to grow, fueled by the need for reliable fixation solutions that support active lifestyles in older adults.

Advances in orthopedic surgical techniques, including the shift toward minimally invasive and outpatient procedures, are also contributing to market growth. Minimally invasive techniques, which focus on reducing tissue damage and accelerating recovery times, require precise and reliable bone cement formulations that can be applied efficiently in confined surgical spaces. Innovations in bone cement, such as improved viscosity and quicker setting times, cater to these needs, supporting surgeons in achieving stable implant fixation with minimal complications. The development of pre-mixed and easy-to-use bone cement delivery systems has made application more convenient, aligning with the increasing popularity of minimally invasive procedures. As healthcare providers seek solutions that enhance procedural efficiency and reduce patient recovery time, the demand for advanced bone cement products continues to rise, supporting market expansion.

Additionally, the increasing adoption of antibiotic-loaded bone cement in orthopedic procedures is driving growth as hospitals and clinics prioritize infection prevention. With the risk of post-surgical infections posing a significant challenge in joint replacements and other implant-based surgeries, antibiotic-loaded bone cement provides an effective solution that combines structural support with localized antimicrobial protection. This dual functionality is especially valuable in revision surgeries, where patients face a higher risk of infection. As healthcare providers emphasize patient safety and successful surgical outcomes, the preference for antibiotic-loaded bone cement has grown, contributing to demand. Together, these factors—an aging population, advancements in minimally invasive surgery, and a focus on infection control—are fueling the expansion of the orthopedic bone cement market, underscoring its essential role in modern orthopedic care.

SCOPE OF STUDY:

The report analyzes the Orthopedic Bone Cement market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Polymethyl Methacrylate (PMMA) Cement, Calcium Phosphate Cement (CPC), Glass Polyalkenoate Cement (GPC), Other Types); Application (Arthroplasty, Kyphoplasty, Vertebroplasty); End-Use (Hospitals, Ambulatory Surgery Centers, Clinics)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -

• Depuy Synthes
• DJO Global
• Elite Surgical
• Exactech
• Groupe Lepine
• Smith & Nephew
• Stryker Corporation
• Synimed
• Teknimed
• Zimmer Biomet

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher. Show more